RxTrials Institute Drug Pipeline Alert

Exelgen, a subsidiary of Commonwealth Biotechnologies, will collaborate with two European-based biotechnology companies.

Both companies have declined to be identified or to disclose contract values at this time.

The partnerships encompass a range of collaborative research activities including medicinal chemistry and application of Exelgen’s LeadHopping technology to identify and progress lead compound series into preclinical studies, according to Commonwealth Biotechnologies.